Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

The company has a long way to go with additional research and development, and it could be several years before the Food and ...

The study is being conducted under a Special Protocol Agreement (SPA) with the U.S. Food and Drug Administration (FDA).

Talen Energy swung to a profit in its latest quarter as certain investments improved with stronger equity markets and declining interest rates. The power producer logged net income attributable to ...

We are on track to complete two important milestones in the first quarter of 2025-first, agreement with the FDA on the design of a PSC pivotal trial for CM-101 and second, reporting new clinical data ...

Looking ahead, Talphera remains optimistic about the potential of Niyad™, leveraging its Breakthrough Device Designation status, and plans to continue advancing its clinical trials with an eye on ...

Neurogene (NASDAQ: NGNE) stock just took a sharp dive, plummeting 44% in a single day. Bad news on Monday caused the ...

The Tigers (7-2, 6-1 ACC) are part of the chase for a trip to the league title game and can’t afford a slip-up with No. 14 ...

A new California law will require a human to sign off on decisions by AI-generated algorithms, while another law requires ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.